Wonderla Holidays Fund Raise of ₹540 Cr

Wonderla Holidays Board Meeting Date

Wonderla Holidays convened a board meeting scheduled for 02 Nov 2026 to approve Q1 FY27 unaudited results. No financial figures disclosed in this advance intimation.

Wonderla Holidays Other Announcement

The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.

Wonderla Holidays Legal & Regulatory

Wonderla Holidays received a GST Show Cause Notice demanding ₹34.28 Crore (inclusive of tax, interest, and penalty). The company is evaluating the notice and will respond.

Value

₹34.28 Cr

Wonderla Holidays Credit Rating

Wonderla Holidays Ltd received a credit rating update from CARE Ratings, reaffirming ratings and revising the outlook for certain long-term facilities.

Wonderla Holidays Annual General Meeting

Wonderla Holidays Limited held its 24th Annual General Meeting on August 19, 2026. Shareholders approved a final dividend of Rs. 2.00 per equity share for FY 2025-26.

Wonderla Holidays Earnings Call Transcript: Key Takeaways

Wonderla reported record Q1 FY27 results with 41% revenue growth driven by the Chennai park scale-up and strong footfalls across existing locations.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.